All cancer types
Results
Phase 1
This trial looked at the combination of taladegib and paclitaxel for people with cancer that had come back after treatment.
The trial was supported by Cancer Research UK. It was open for people to join between 2015 and 2017. The team analysed the results in 2020.
Recruitment start: 4 September 2015
Recruitment end: 27 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ros Glasspool
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Ignyta Inc
NHS Greater Glasgow and Clyde
NIHR Clinical Research Network: Cancer
Last reviewed: 14 September 2021
CRUK internal database number: 12213
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
